1-3 of 3
Xiaoqing LI, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-CD38 Monoclonal Antibody Daratuzumab Improve Responses to Chemotherapy-Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Case Report

Xiaoqing LI, MD, Gang An, Xin Du, Weihong Chen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42.
https://doi.org/10.1182/blood-2020-143390
Published: 2020
Journal Articles

Anti-CD19 Chimeric Antigen Receptor T Cell Treatment of Relapsed /Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Resistant to Bruton's Tyrosine Kinase (BTK) Inhibitor

Weihong Chen, MD, Xin Du, Wenyujing Zhou, Changru Luo, Xiaoqing LI, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36.
https://doi.org/10.1182/blood-2020-143099
Published: 2020
Journal Articles

The Prognostic Impact of Dynamic Changes of Genetic Risk Stratification in Multiple Myeloma

Huishou Fan, Jiahui Liu, Chenglu Yuan, Xue-Han Mao, MD, Xiaoqing LI, MD, Xin Du, Zengjun Li, Mu Hao, Yuting Yan, Shuhui Deng, MD, Chenxing Du, MD, Chengwen Li, Jiawei Zhao, Shuhua Yi, MD, Dehui Zou, MD, Yaozhong Zhao, Fenghuang Zhan, MD PhD, Yu-Tzu Tai, PhD, Jianxiang Wang, MD, Kenneth Anderson, MD, Lugui Qiu, MD, Gang An, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-139345
Published: 2020